These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6431057)

  • 41. Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis.
    De Laurentiis A; Pisera D; Caruso C; Candolfi M; Mohn C; Rettori V; Seilicovich A
    Neuroimmunomodulation; 2002; 10(1):30-9. PubMed ID: 12207161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy.
    Rastogi P; Mehrotra TN; Agarwala RK; Singh VS
    J Assoc Physicians India; 1991 Aug; 39(8):606-8. PubMed ID: 1814875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonpuerperal lactation and normal prolactin regulation.
    Malarkey WB
    J Clin Endocrinol Metab; 1975 Feb; 40(2):198-204. PubMed ID: 1168856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of dopamine and neuroleptics on plasma growth hormone and prolactin in normal men.
    Langer G; Sachar EJ; Halpern FS
    Psychoneuroendocrinology; 1978 Apr; 3(2):165-9. PubMed ID: 704750
    [No Abstract]   [Full Text] [Related]  

  • 46. Functional evaluation of prolactin secretion in patients with hypothalamic-pituitary disorders.
    Tolis G; Goldstein M; Friesen HG
    J Clin Invest; 1973 Apr; 52(4):783-8. PubMed ID: 4632690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perinatal glucocorticoid treatment disrupts the hypothalamo-lactotroph axis in adult female, but not male, rats.
    McArthur S; Siddique ZL; Christian HC; Capone G; Theogaraj E; John CD; Smith SF; Morris JF; Buckingham JC; Gillies GE
    Endocrinology; 2006 Apr; 147(4):1904-15. PubMed ID: 16439449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Single daily dose of diphenylhydantoin in treating epilepsy].
    Shen DL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Jun; 18(3):145-7. PubMed ID: 3932025
    [No Abstract]   [Full Text] [Related]  

  • 49. Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington's chorea.
    Müller EE; Parati EA; Panerai AE; Cocchi D; Caraceni T
    Neuroendocrinology; 1979; 28(5):313-9. PubMed ID: 155781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of phenytoin and valproate in previously untreated adult epileptic patients.
    Turnbull DM; Rawlins MD; Weightman D; Chadwick DW
    J Neurol Neurosurg Psychiatry; 1982 Jan; 45(1):55-9. PubMed ID: 6801213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Similar response to dopaminergic or anti-dopaminergic drugs in acromegaly.
    Tater D; Maudelonde T; Sudre Y; Besson G; Bercovici JP
    Horm Metab Res; 1984 Feb; 16(2):104-5. PubMed ID: 6706287
    [No Abstract]   [Full Text] [Related]  

  • 52. Prolactin and growth hormone response in induced hypoglycaemia in obese patients.
    Micić DD; Djurić DS; Manojlović DL; Dragasević MM
    Endocrinologie; 1981; 19(2):137-41. PubMed ID: 7020062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prolactin and growth hormone responses in the amenorrhea-galactorrhea syndrome.
    Hagen TC; Sill AJ; Garthwaite TL; Halverson G; Borkowf HI
    Obstet Gynecol; 1980 Aug; 56(2):204-7. PubMed ID: 7190256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormal prolactin and growth hormone responses to thyrotropin releasing hormone in chronic alcoholic men.
    Van Thiel DH; Smith WI; McClain CJ; Lester R
    Curr Alcohol; 1979; 5():71-9. PubMed ID: 114360
    [No Abstract]   [Full Text] [Related]  

  • 55. Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: implications for antiepileptic action and mental function.
    Pratt JA; Jenner P; Johnson AL; Shorvon SD; Reynolds EH
    J Neurol Neurosurg Psychiatry; 1984 Oct; 47(10):1131-3. PubMed ID: 6438278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma DOPA levels and growth hormone response to levodopa in parkinsomism.
    Galea-Debono A; Jenner P; Marsden CD; Parkes JD; Tarsy D; Walters J
    J Neurol Neurosurg Psychiatry; 1977 Feb; 40(2):162-7. PubMed ID: 864480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Carbamazepine (Tegretol) or phenytoin in the treatment of focal motor epilepsy or generalized epilepsy? A controlled clinical trial].
    Kosteljanetz M; Christiansen J; Dam AM; Hansen BS; Lyon BB; Pedersen H; Dam M
    Ugeskr Laeger; 1979 Apr; 141(15):989-91. PubMed ID: 108827
    [No Abstract]   [Full Text] [Related]  

  • 58. Hormones, dopamine receptors and schizophrenia.
    Meltzer HY; Busch D; Fang VS
    Psychoneuroendocrinology; 1981; 6(1):17-36. PubMed ID: 7244055
    [No Abstract]   [Full Text] [Related]  

  • 59. Adrenal cortex hormones in male epileptic patients before and during a 2-year phenytoin treatment.
    Ostrowska Z; Buntner B; Rościszewska D; Guz I
    J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):374-8. PubMed ID: 3129539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of levodopa on serum levels of anterior pituitary hormones in man.
    Boden G; Lundy LE; Owen OE
    Neuroendocrinology; 1972; 10(5):309-15. PubMed ID: 4350777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.